Literature DB >> 9818892

Physiologic MRI of a tumefactive multiple sclerosis lesion.

T Ernst1, L Chang, I Walot, K Huff.   

Abstract

Structural and physiologic MRI were performed after subacute onset of left hemiparesis in a patient with MS. MRI showed a large ring-enhancing lesion with surrounding edema and mass effect; differential diagnosis included a neoplasm or a large MS plaque. Physiologic MRI showed reduced blood flow and magnetization transfer, as well as increased diffusion, in the large lesion. Because these findings suggested a tumefactive MS plaque rather than a neoplasm, the patient received steroid treatment for acute MS exacerbation. Three months later the patient improved clinically and on MRI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818892     DOI: 10.1212/wnl.51.5.1486

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 2.  MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Authors:  A Seewann; C Enzinger; M Filippi; F Barkhof; A Rovira; A Gass; D Miller; X Montalban; A Thompson; T Yousry; M Tintore; N de Stefano; J Palace; M Rovaris; C Polman; F Fazekas
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

Review 3.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

4.  Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.

Authors:  Rocco Totaro; C Di Carmine; A Splendiani; S Torlone; L Patriarca; C Carrocci; S Sciamanna; C Marini; A Carolei
Journal:  Neurol Sci       Date:  2016-04-15       Impact factor: 3.307

Review 5.  Tumefactive demyelinating lesions: nine cases and a review of the literature.

Authors:  Lei Xia; Song Lin; Zhong-cheng Wang; Shao-wu Li; Li Xu; Jing Wu; Shu-yu Hao; Chuan-chuan Gao
Journal:  Neurosurg Rev       Date:  2009-01-27       Impact factor: 3.042

6.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

7.  Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report.

Authors:  Alex Rovira; Imma Pericot; Juli Alonso; Jordi Rio; Elisenda Grivé; Xavier Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

8.  Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.

Authors:  N Abou Zeid; I Pirko; B Erickson; S D Weigand; K M Thomsen; B Scheithauer; J E Parisi; C Giannini; L Linbo; C F Lucchinetti
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

Review 9.  Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.

Authors:  Simon Faissner; Robert Hoepner; Carsten Lukas; Andrew Chan; Ralf Gold; Gisa Ellrichmann
Journal:  Ther Adv Neurol Disord       Date:  2015-09       Impact factor: 6.570

10.  Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.

Authors:  Marc C Mabray; Benjamin A Cohen; Javier E Villanueva-Meyer; Francisco E Valles; Ramon F Barajas; James L Rubenstein; Soonmee Cha
Journal:  AJR Am J Roentgenol       Date:  2015-11       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.